Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CPA1 | P15085 | 2/20 | 0.42 |
| ▸ | CPB1 | P15086 | 1/20 | 0.42 |
| ▸ | CPA3 | P15088 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.38 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL262673 | 0.81 | HTT (0.45) | CYP1A2TSHRALDH1A1HSD17B10POLB | |
| SCHEMBL30437060 | 0.81 | GABBR2 (0.48) | CYP1A2TSHRPOLBCYP26A1CPA1 | |
| SCHEMBL658742 | 0.81 | GABBR2 (0.48) | CYP1A2TSHRPOLBCYP26A1CPA1 | |
| SCHEMBL8771210 | 0.79 | SLC18A3 (0.46) | CYP1A2TSHRCYP26A1CPA1CPB1 | |
| SCHEMBL27809268 | 0.79 | CYP26A1 (0.44) | CYP1A2TSHRCYP26A1CPA1CPB1 | |
| SCHEMBL1492655 | 0.79 | HTT (0.46) | CYP1A2TSHRHTTCYP2C19CYP2C9 | |
| SCHEMBL10692703 | 0.78 | CYP1A2 (0.57) | CYP1A2TSHRKDM4EALDH1A1HSD17B10 | |
| SCHEMBL5720936 | 0.78 | CYP26A1 (0.46) | CYP1A2TSHRCYP26A1KMT2ACPA1 | |
| SCHEMBL1613850 | 0.78 | HTT (0.49) | CYP1A2TSHRKDM4EALDH1A1CYP26A1 | |
| SCHEMBL31296529 | 0.78 | HTT (0.49) | CYP1A2TSHRKDM4EALDH1A1CYP26A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115867346-B | Kinase inhibitors | GB005股份有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20230219923-A1 | KINASE INHIBITORS | VIDYA THERAPEUTICS, INC. | 2023-07-13 | — | — | US | disclosed |
| US-20230219923-A1 | KINASE INHIBITORS | VIDYA THERAPEUTICS, INC. | 2023-07-13 | — | — | US | disclosed |
| CN-115867346-A | Kinase inhibitors | GB005股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219923-A1 | KINASE INHIBITORS | BTK, ABL1, LYN | CYP1A2 3142/4885TSHR 2436/4885KDM4E 1060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.